Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism-Reference-Cited by-同舟云学术

Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism

Published:2011-06-21 Issue:7 Volume:26 Page:1425-1436
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Atkins Gerald J,Rowe Peter S,Lim Hui P,Welldon Katie J,Ormsby Renee,Wijenayaka Asiri R,Zelenchuk Lesya,Evdokiou Andreas,Findlay David M

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.345/fullpdf

Reference67 articles.

1. Wnt signaling: a key regulator of bone mass;Baron;Curr Top Dev Biol.,2006

2. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength;Li;J Bone Miner Res.,2008

3. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling;ten Dijke;J Bone Joint Surg Am.,2008

4. Identification of a 52-kb deletion downstream of the SOST gene in patients with van Buchem disease;Balemans;J Med Genet.,2002

5. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population;Staehling-Hampton;Am J Med Genet.,2002

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix first, minerals later: fine-tuned dietary phosphate increases bone formation in zebrafish;JBMR Plus;2024-06-18

2. The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health;Current Osteoporosis Reports;2024-04-22

3. Osteocyte-mediated mechanical response controls osteoblast differentiation and function;Frontiers in Physiology;2024-03-11

4. Vitamin D activity in osteoblasts and osteocytes;Feldman and Pike' s Vitamin D;2024

5. Romosozumab in osteoporosis: yesterday, today and tomorrow;Journal of Translational Medicine;2023-09-27